Feasibility and advantage of adding (131)I-MIBG to (90)Y-DOTATOC for treatment of patients with advanced stage neuroendocrine tumors. [electronic resource]
By: Contributor(s): Producer: 20150627Description: 38 p. digitalISSN:- 2191-219X
Publication Type: Journal Article
There are no comments on this title.
-
37421
Stereotactic LINAC radiosurgery for the treatment of brainstem cavernomas.
by Fuetsch, M -
37422
Newborn hearing screening at Rajavithi Hospital, Thailand: hearing loss in infants not admitting in intensive care unit.
by Tungvachirakul, Viruch -
37423
Upregulation of insulin-like growth factor and interleukin 1β occurs in neurons but not in glial cells in the cochlear nucleus following cochlear ablation.
by Fuentes-Santamaría, Verónica -
37424
Diagnosis of Schmallenberg virus infection in malformed lambs and calves and first indications for virus clearance in the fetus.
by De Regge, Nick -
37425
Prevalence of hearing impairment in children at risk.
by Botelho, Fernanda Alves -
37426
Long-term outcome after resection of brainstem hemangioblastomas in von Hippel-Lindau disease.
by Wind, Joshua J -
37427
Localization of CHMP2B-immunoreactivity in the brainstem of Lewy body disease.
by Kurashige, Takashi -
37428
Analysis of audiological results of patients referred from newborn hearing screening program.
by Song, Chan Il -
37429
Prevalence of vestibular dysfunction in patients with vestibular schwannoma using video head-impulses and vestibular-evoked potentials.
by Taylor, Rachael L -
37430
d-Methionine reduces tobramycin-induced ototoxicity without antimicrobial interference in animal models.
by Fox, Daniel J -
37431
Brain involvement in patients with inflammatory bowel disease: a voxel-based morphometry and diffusion tensor imaging study.
by Zikou, Anastasia K -
37432
Effects of substance P during the recovery of hearing function after noise-induced hearing loss.
by Kanagawa, Eiju -
37433
Betahistine exacerbates amikacin ototoxicity.
by Aksoy, Fadlullah -
37434
The use of proton therapy in the treatment of benign or low-grade pediatric brain tumors.
by Eaton, Bree R -
37435
Otological findings in pediatric patients with hypogammaglobulinemia.
by Tavakol, Marzieh -
37436
Intracochlear Bleeding Enhances Cochlear Fibrosis and Ossification: An Animal Study.
by Ryu, Kyeung A -
37437
Pharmacological, but not genetic, alteration of neural Epo modifies the CO
by Laouafa, Sofien -
37438
Good outcome of brain stem progressive multifocal leukoencephalopathy in an immunosuppressed renal transplant patient: Importance of early detection and rapid immune reconstitution.
by Sauer, Roland -
37439
Cerebral microbleeds are associated with physical frailty: a community-based study.
by Chung, Chih-Ping -
37440
Management Outcome of Brainstem Arteriovenous Malformations: The Role of Radiosurgery.
by Yang, Wuyang
Feasibility and advantage of adding (131)I-MIBG to (90)Y-DOTATOC for treatment of patients with advanced stage neuroendocrine tumors.
APA
Bushnell D. L., Madsen M. T., O'cdorisio T., Menda Y., Muzahir S., Ryan R. & O'dorisio M. S. (20150627). Feasibility and advantage of adding (131)I-MIBG to (90)Y-DOTATOC for treatment of patients with advanced stage neuroendocrine tumors. : EJNMMI research.
Chicago
Bushnell David L, Madsen Mark T, O'cdorisio Thomas, Menda Yusuf, Muzahir Saima, Ryan Randi and O'dorisio M Sue. 20150627. Feasibility and advantage of adding (131)I-MIBG to (90)Y-DOTATOC for treatment of patients with advanced stage neuroendocrine tumors. : EJNMMI research.
Harvard
Bushnell D. L., Madsen M. T., O'cdorisio T., Menda Y., Muzahir S., Ryan R. and O'dorisio M. S. (20150627). Feasibility and advantage of adding (131)I-MIBG to (90)Y-DOTATOC for treatment of patients with advanced stage neuroendocrine tumors. : EJNMMI research.
MLA
Bushnell David L, Madsen Mark T, O'cdorisio Thomas, Menda Yusuf, Muzahir Saima, Ryan Randi and O'dorisio M Sue. Feasibility and advantage of adding (131)I-MIBG to (90)Y-DOTATOC for treatment of patients with advanced stage neuroendocrine tumors. : EJNMMI research. 20150627.